Wishful thinking. The MC is still way too high. When a drug fails the company can fall to shell value (less than 10 million MC). This could fall to a few cents. Look at what happened to Innate Immunotherapeutics. Let's see what happens. If there is debt then that can be a company killer.
Ann: Bionomics' PTSD Trial Results, page-17
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
